Chemotherapy Clinical Trials in Guangzhou, Guangdong
21 recruitingGuangzhou, Guangdong, China
Showing 1–20 of 21 trials
Recruiting
Phase 3
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
ChemotherapyRadiotherapyImmune Checkpoint Inhibitor+1 more
Sun Yat-sen University380 enrolled3 locationsNCT05941741
Recruiting
Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy
Targeted TherapyImmunotherapyHepatocellular Carcinoma (HCC)+2 more
Nanfang Hospital, Southern Medical University90 enrolled1 locationNCT07436845
Recruiting
Not Applicable
Acupuncture and Compression for the Prevention of CIPN in Breast Cancer Patients
Breast CancerChemotherapy-induced Peripheral Neuropathy (CIPN)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University384 enrolled1 locationNCT07377279
Recruiting
Phase 2
QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT
BevacizumabHepatecellular CarcinomaRALOX-HAIC（Hepatic Arterial Infusion Chemotherapy With Raltitrexed and Oxaliplatin+3 more
Nanfang Hospital, Southern Medical University38 enrolled1 locationNCT07327788
Recruiting
Phase 3
Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRC
Weight LossNeoadjuvant Chemotherapy
Sixth Affiliated Hospital, Sun Yat-sen University60 enrolled1 locationNCT06998758
Recruiting
Phase 3
Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC
Chemotherapy EffectHepato Cellular Carcinoma (HCC)
Linhui Peng326 enrolled1 locationNCT07267806
Recruiting
Phase 3
Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and Apatinib for Advanced HCC
Chemotherapy EffectBCLC Stage C Hepatocellular Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University262 enrolled1 locationNCT06172205
Recruiting
Phase 2
Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell CarcinomaChemoradiotherapyToripalimab+2 more
Sun Yat-sen University69 enrolled1 locationNCT07086469
Recruiting
Phase 2
Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer
ChemotherapyTargeted TherapyImmunotherapy+2 more
Sun Yat-sen University57 enrolled1 locationNCT06764680
Recruiting
Bladder Cancer Staging and Prediction of New Adjuvant Chemotherapy Efficacy Based on Deep Learning and Transfer Learning in Ultrasound-Magnetic Resonance-Pathology Multimodal Multiscale
Bladder CancerNeoadjuvant ChemotherapyDeep Learning+2 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University480 enrolled1 locationNCT07051083
Recruiting
Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
Circulating Tumor CellNasopharyngeal CarcinomaEffects of Chemotherapy+1 more
Sun Yat-sen University50 enrolled1 locationNCT04544969
Recruiting
Not Applicable
Correlation of Timing of Pegfilgrastim Administration and PIBP.
Breast CancerChemotherapyQuality of Life+3 more
Guangdong Provincial People's Hospital156 enrolled1 locationNCT05841186
Recruiting
Phase 3
Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC
Hepatocellular CarcinomaChemotherapy EffectChemotherapeutic Toxicity
Sun Yat-sen University540 enrolled1 locationNCT06041477
Recruiting
Predicting Gastric Cancer Response to Chemo With Multimodal AI Model
Gastric CancerChemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University500 enrolled1 locationNCT06451393
Recruiting
Not Applicable
Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients
Rectal CancerChemotherapy Effect
Sun Yat-sen University392 enrolled1 locationNCT06043999
Recruiting
Phase 2
Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial.
PD-L1Locally Advanced Nasopharyngeal CarcinomaInduction Chemotherapy+1 more
Sun Yat-sen University36 enrolled1 locationNCT05397769
Recruiting
Phase 3
Topotecan and Melphalan for Retinoblastoma
Chemotherapy EffectRetinoblastoma
Sun Yat-sen University50 enrolled1 locationNCT04799002
Recruiting
Phase 3
Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma
ChemotherapyRadiotherapyNasopharyngeal Carcinoma+1 more
Sun Yat-sen University226 enrolled6 locationsNCT04453813
Recruiting
Phase 3
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
ChemotherapyRadiotherapyNasopharyngeal Cancer+1 more
Sun Yat-sen University388 enrolled6 locationsNCT04453826
Recruiting
Phase 3
Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma
ChemotherapyRadiotherapyNasopharyngeal Carcinoma
Sun Yat-sen University508 enrolled6 locationsNCT04448522